During the past decade, InFocus Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "InFocus Clinical Research" are "Overactive Bladder" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "InFocus Clinical Research" in a lesser frequency.

Most popular intervention types in "InFocus Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (1 trials), "Metformin XR" (1 trials), "Placebo" (1 trials), "Placebo matching with Dapagliflozin" (1 trials) and "Placebo matching with Saxagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "InFocus Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "InFocus Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in InFocus Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in InFocus Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".